Breast cancer has been the subject of sustained clinical investigation across multiple research sites.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID	Title	Status	Phase
NCT01385137	S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy	COMPLETED	PHASE3
NCT05896189	Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors	RECRUITING	—
NCT00874211	S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	COMPLETED	—
NCT01674140	S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25	RECRUITING	—
NCT05896189	Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors	RECRUITING	—
NCT02032823	Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT01547741	Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer	UNKNOWN	PHASE3
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25	RECRUITING	—
NCT06760637	Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease	RECRUITING	PHASE3

Related Pages

All Breast cancer trials All trials in Nampa, United States